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Abstract The innate immune sensor retinoic acid-inducible gene I (RIG-I) detects cytosolic viral
RNA and requires a conformational change caused by both ATP and RNA binding to induce an
active signaling state and to trigger an immune response. Previously, we showed that ATP
hydrolysis removes RIG-I from lower-affinity self-RNAs (La¨ssig et al., 2015), revealing how ATP
turnover helps RIG-I distinguish viral from self-RNA and explaining why a mutation in a motif that
slows down ATP hydrolysis causes the autoimmune disease Singleton-Merten syndrome (SMS).
Here we show that a different, mechanistically unexplained SMS variant, C268F, which is localized
in the ATP-binding P-loop, can signal independently of ATP but is still dependent on RNA. The
structure of RIG-I C268F in complex with double-stranded RNA reveals that C268F helps induce a
structural conformation in RIG-I that is similar to that induced by ATP. Our results uncover an
unexpected mechanism to explain how a mutation in a P-loop ATPase can induce a gain-of-function
ATP state in the absence of ATP.
DOI: https://doi.org/10.7554/eLife.38958.001
Introduction
Retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) are cytosolic innate immune sensors that
recognize viral double-stranded (ds)RNAs. RLRs (RIG-I, MDA5 and LGP2) are members of the so-
called Superfamily II (SF2) helicases/translocases. They share a multi-domain architecture that con-
sists of a central SF2 ATPase domain accompanied by two N-terminal tandem caspase activation
and recruitment domains (2CARD, only in RIG-I and MDA5) and a C-terminal regulatory domain
(CTD or RD) (Rawling and Pyle, 2014). The SF2 domain itself is built out of an N-terminal RecA-like
domain (1A) and a C-terminal RecA-like domain (2A) that together form an ATP-binding pocket, as
well as an insertion domain (domain 2B). SF2 and RD are crucial for RNA-recognition of RLRs,
whereas 2CARD communicates successful RNA-binding events to downstream signaling factors
(Jiang et al., 2011; Kowalinski et al., 2011; Luo et al., 2011). Specifically, RIG-I detects dsRNA
ends harbouring 5’ tri- or diphosphates (Goubau et al., 2014; Schlee et al., 2009; Schmidt et al.,
2009). Simultaneous binding of an RNA ligand and ATP to RIG-I switches the protein into an active
state in which the otherwise shielded 2CARD is released (Zheng et al., 2015). Activated RIG-I
homo-tetramerizes via 2CARD (Jiang et al., 2012) and nucleates the polymerisation of its adapter
protein, mitochondrial antiviral-signaling (MAVS), to elicit the innate immune signaling cascade
(Peisley et al., 2014; Wu et al., 2014).
The similarity of epitopes of viral RNA recognized by RLRs, in particular dsRNA stems, to some
endogenous ribonucleic acids has required the immune system to develop mechanisms besides
merely recognizing 5’-di/triphosphate-containing RNA ends to discriminate self from non-self. Self-
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ribonucleic acids for instance are shielded from RLRs by introducing 2’O-methylations or by destabi-
lizing double-stranded parts through A-to-I editing (Chung et al., 2018; Devarkar et al., 2016;
Liddicoat et al., 2015; Schuberth-Wagner et al., 2015). In addition, we and others have been able
to show that the SF2 domain of RLRs itself confers a proof-reading activity by removing RIG-I from
self-RNA so as to avoid autoimmunity (Anchisi et al., 2015; La¨ssig et al., 2015; Louber et al.,
2015; Rawling et al., 2015). In particular, ATP turnover can lead to translocation on dsRNA stems
that could remove the protein from the RNA and reinstall the inactivated state (Myong et al., 2009;
Yao et al., 2015).
Deficiencies in any of these mechanisms can lead to immune recognition of self-RNAs
(Ahmad et al., 2018; Chiang et al., 2018). For instance, single-nucleotide polymorphisms (SNPs) in
RLR genes are known to cause system-wide autoimmune diseases such as Aicardi-Goutie`re syn-
drome (AGS) (Oda et al., 2014; Rice et al., 2014), Singleton-Merten syndrome (SMS) (Jang et al.,
2015; Rutsch et al., 2015), systemic lupus erythematosus (SLE) (Cunninghame Graham et al.,
2011; Pettersson et al., 2017; Van Eyck et al., 2015) or type 1 diabetes (Liu et al., 2009;
Smyth et al., 2006). The molecular basis for the development of these diseases is in many cases not
understood, because structural data on these RLR variants have been missing.
In this work, we present the biochemical and structural analysis of the RIG-I SMS variant C268F
and unveil an ATP-independent signaling mechanism. We show that active site rearrangements of
several amino acid side chains in RIG-I C268F mimic an ATP-bound state and activate the protein for
signaling upon recognition of RNA ligands in the absence of ATP.
Results and discussion
The RIG-I SMS variants C268F and E373A are located within SF2 ATP binding and hydrolysis motifs I
and II, respectively, (Fairman-Williams et al., 2010) (Figure 1—figure supplement 1) and were pre-
viously shown to be constitutively active in reporter cells without any external dsRNA trigger
(Jang et al., 2015; La¨ssig et al., 2015) (Figure 1—figure supplement 2A). RIG-I E373A’s enhanced
immune signaling ability can be explained by proficient ATP binding but reduced ATP hydrolysis,
since the motif II glutamate is implicated in positioning and polarizing the attacking water molecule
in the hydrolysis reaction. The stabilized ATP state leads to increased binding of and activation by
endogenous dsRNA (La¨ssig et al., 2015; Louber et al., 2015). By contrast, the molecular basis for
activation of RIG-I C268F is still unknown as this mutation is located in motif I, which is normally asso-
ciated with ATP binding and which is critical for RIG-I activation. For instance, a designed and widely
used mutant with a defect in the invariant ATP phosphate-binding motif I lysine, K270A, possesses
reduced ATP binding properties (Rawling et al., 2015) and the RIG-I K270A/I mutant is deficient in
inducing an immune response (La¨ssig et al., 2015; Yoneyama et al., 2005). By contrast, the RIG-I
SMS variant C268F shows the opposite effect and is constitutively active, although this mutation is
only two amino acids away from K270A in the same ATP phosphate-binding ‘P-loop’ in motif I (Fig-
ure 1—figure supplement 2A).
To analyze whether the autoimmune activity of the SMS variant RIG-I C268F is RNA-dependent,
we designed a double-mutant that is defective in RNA-binding and carried out interferon (IFN)-b-
promoter-driven luciferase reporter assays with overexpressed proteins in HEK293T RIG-I KO cells
(Figure 1A). In particular, we used a previously described T347A point mutation in the RNA-binding
interface of the N-terminal RecA-like domain (1A) (Figure 1—figure supplement 1), that abrogates
the signaling of wild type (wt) RIG-I in infected cells and decreases the affinity for dsRNA in vitro
(La¨ssig et al., 2015). Our assays show, that RIG-I C268F, T347A fails to induce the IFN-b promoter
in uninfected as well as in 19mer 5’-triphosphate (ppp)-dsRNA-stimulated cells, indicating that the
RIG-I SMS single-mutant C268F induces immune signaling only if bound to endogenous or trans-
fected RNA. In addition, competition assays of RIG-I C268F titrated with signaling-deficient RIG-I
lacking the 2CARD domain (RIG-I D2CARD) or with RIG-I D2CARD E373Q also gradually decreased
the IFN-b promoter-driven luciferase activity (Figure 1—figure supplement 2B). Thus, RIG-I C268F
as well as RIG-I D2CARD (E373Q) seem to recognize identical RNA substrates which are, however,
saturated with signaling-deficient RIG-I D2CARD (E373Q) at higher transfected DNA concentrations
thus preventing an immune response. Furthermore, we can exclude the possibility that the RIG-I
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Figure 1. The RIG-I Singleton-Merten syndrome variant C268F signals in response to endogenous dsRNA. (A) Fold
change of interferon (IFN)-b promoter-driven luciferase activity in uninfected HEK293T RIG-I KO cells or in cells
stimulated with a 19mer 5’-triphosphate (ppp)-dsRNA upon overexpression of different RIG-I mutants. Cells were
co-transfected with RIG-I expression vectors and p-125luc/pGL4.74 reporter plasmids, and stimulated with ppp-
dsRNA 6 hr post transfection. Firefly luciferase activities were determined in respect to Renilla luciferase activities
16 hr after RNA stimulation. All ratios were normalized to an empty vector control. n = 4–12, error bars represent
mean values + standard error of the mean (SEM). (B) Fluorescence anisotropy changes measured after titrating
RIG-I or RIG-I C268F in the presence or absence of ATP into solutions containing a fluorescently labeled 14mer
dsRNA. All binding curves were fit to a one-site binding equation using R. n = 4, error bars represent mean values
± standard deviation (SD).
DOI: https://doi.org/10.7554/eLife.38958.002
The following figure supplements are available for figure 1:
Figure supplement 1. Location of RIG-I amino acid substitutions used in Figure 1.
DOI: https://doi.org/10.7554/eLife.38958.003
Figure supplement 2. Comparison of the autoimmune signaling activity of RIG-I Singleton-Merten syndrome
variants.
DOI: https://doi.org/10.7554/eLife.38958.004
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C268F SMS mutation leads to a liberation of the 2CARD signaling module in the absence of RNA,
for example by unfolding SF2. Instead, signaling by the RIG-I C268F SMS variant is dependent on
2CARD release triggered by binding to RNA molecules, as it is in wild type RIG-I.
To validate the intact RNA-binding properties of RIG-I C268F, we performed in vitro fluorescence
anisotropy assays of purified proteins with a labeled hairpin (hp) RNA containing non-base-paired
RNA ends (Figure 1B). We chose to use a double-stranded RNA ligand without blunt ends to sup-
press the dominant binding of RIG-I’s RD to terminal RNA base pairs and to simulate recognition of
endogenous-like RNA species that could be present within the cytosol. As expected, wild type RIG-I
shows a moderate binding affinity to this ligand that is further decreased in the presence of ATP. By
contrast, RIG-I C268F displays an already increased affinity to the hpRNA that is even enhanced
in the presence of ATP. This confirms the previous results for RIG-I C268F showing an increased co-
purification with endogenous RNA molecules (La¨ssig et al., 2015) and indicates that RIG-I C268F
has two conformations (apo and ATP-bound) that have increased dsRNA affinity.
Since an intact SF2 ATPase domain of RIG-I is needed so that signaling only occurs when foreign
RNA molecules are recognized (Louber et al., 2015; Rawling et al., 2015), we further analyzed the
ATP binding and hydrolysis properties of RIG-I C268F in vitro. The ATP-binding-deficient and hydro-
lysis-deficient motif I mutant RIG-I K270I and the hydrolysis-deficient motif II mutant RIG-I E373Q
both served as references. ATP hydrolysis assays with 32P-labeled ATP confirmed a loss of catalytic
activity of RIG-I C268F and of both motif I and II mutants in the presence of dsRNA (Figure 2A). In
accordance with our RNA-binding experiments, this evidence supports a model in which RIG-I
C268F has defects in dissociating from endogenous RNA, because it lacks the capability for ATP
turnover and hence translocation. To further analyze the ATP-binding properties of the RIG-I SMS
variant, we conducted a tryptophan fluorescence-based FRET assay with MANT-ATP (Rawling et al.,
2015) (Figure 2B). In the absence of any RNA ligand, both wild type RIG-I and ATP-hydrolysis-defi-
cient RIG-I E373Q show comparable affinities for MANT-ATP and MANT-ATPgS in the low mM range
(Table 1). As expected, ATP-binding-deficient RIG-I K270I has a reduced affinity for ATP (in the
medium mM range). In accordance with previous data (Kohlway et al., 2013), the presence of RNA
increases the affinity of wtRIG-I and RIG-I E373Q, but not of RIG-I K270I for MANT-ATP or MANT-
ATPgS. Interestingly, like RIG-I K270I, the RIG-I SMS variant C268F displays reduced ATP-binding
affinities compared to that of wtRIG-I or RIG-I E373Q independently of the availability of an RNA
ligand (Figure 2B, Table 1). This is puzzling as both RNA and ATP binding are normally needed to
induce a molecular switch within RIG-I in order to release the 2CARD module and to activate an
immune response (Shah et al., 2018; Zheng et al., 2015). RIG-I C268F might thus be able to signal
even in the absence of a bound ATP molecule. However, even though it is possible that under cellu-
lar conditions of 1 mM ATP or even higher, ATP is still bound by both motif I mutants, the molecular
switch to release 2CARD is only triggered in RIG-I C268F but not in RIG-I K270I (Figure 1—figure
supplement 2A). These peculiarities of the ATP-bound states of the motif I mutants need to be
addressed in future studies.
To further investigate the influence of ATP binding to RIG-I C268F, we mutated two
residues that are implicated in ATP adenine recognition, R244A and Q247A (Figure 2—figure sup-
plement 1), thereby further lowering the ATP-binding affinity of the SMS mutant, and tested the
ability of the resulting triple-mutant to induce an immune response (Figure 2C). We expected to see
no decrease in the autoimmune signaling activity of the triple-mutant compared to that of the RIG-I
SMS single-mutant if the single mutant was not able to bind ATP under cellular conditions. However,
compared to the SMS variant itself, the IFN-b promoter activity of the ATP-binding mutant RIG-I
R244A, Q247A, C268F was reduced, albeit still significantly higher than that of wild type RIG-I.
Hence, these data support a model in which RIG-I C268F is able to release its 2CARD domain and
start a signaling cascade by a process that is at least partly independent of ATP.
In order to elucidate the molecular basis of autoimmune signaling by RIG-I C268F, we went on to
crystalize RIG-I D2CARD C268F in the presence of a 14mer dsRNA and ADPBeFx or ATP and deter-
mined the corresponding structures (Figure 3—figure supplement 1A). Intriguingly, despite an
overall high structural similarity to wtRIG-I D2CARD bound to dsRNA (Jiang et al., 2011), the SMS
mutant shows crucial amino acid side chain rearrangements in the active site that stabilize the pro-
tein in an activated state but prevent binding and co-crystalization of a nucleotide (Figure 3A, Fig-
ure 3—figure supplement 1B). In particular, the bulky F268 side chain displaces the evolutionary
invariant motif I K270 from its central ATP phosphate-binding position in the P-loop, into a position
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Figure 2. The RIG-I Singleton-Merten syndrome variant C268F is catalytically dead and has reduced ATP-binding-properties. (A) ATP hydrolysis activity
of RIG-I, the RIG-I Singleton-Merten syndrome (SMS) variant C268F and the RIG-I motif I and II mutants K270I and E373Q. RIG-I proteins were
incubated with [g-32P]-ATP in the presence or absence of a 12mer dsRNA for 15 min at room temperature and free phosphate was separated from ATP
by thin layer chromatography. (B) Affinity of RIG-I, RIG-I C268F and the RIG-I motif I and II mutants to MANT-ATP or MANT-ATPgS measured by
tryptophan fluorescence Fo¨rster resonance energy transfer to the MANT-nucleotide. Proteins were incubated with increasing amounts of nucleotides in
the presence or absence of a 14mer dsRNA. MANT fluorescence was recorded minus a MANT-nucleotide-only control. n = 4, error bars represent
mean values ± SD. (C) Fold change of interferon (IFN)-b promoter-driven luciferase activity in uninfected HEK293T RIG-I KO cells or in cells stimulated
with a 19mer 5’-triphosphate (ppp)-dsRNA upon overexpression of different RIG-I mutants. Cells were co-transfected with RIG-I expression vectors and
p-125luc/pGL4.74 reporter plasmids, and stimulated with ppp-dsRNA 6 hr post transfection. Firefly luciferase activities were determined in respect to
Renilla luciferase activities 16 hr after RNA stimulation. All ratios were normalized to an empty vector control. n = 4–12, error bars represent mean
values + SEM.
DOI: https://doi.org/10.7554/eLife.38958.005
The following figure supplement is available for figure 2:
Figure supplement 1. Location of RIG-I amino-acid substitutions used in Figure 2.
DOI: https://doi.org/10.7554/eLife.38958.006
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where the Ne of K270 is situated at a site normally occupied by the Mg2+ ion (Video 1). As a result,
K270 now forms a salt bridge with E702 from the C-terminal RecA-like domain 2A, which in turn
occupies the ATP g-phosphate binding site. The resulting overall conformation resembles the ATP-
bound state of RIG-I, but without ATP, and could thus explain how C268F is able to signal indepen-
dently of any nucleotide. In order to clarify the impact of the salt bridge, we mutated both side
chains in RIG-I C268F and analyzed the resulting double-mutants in our IFN-b promoter activity assay
(Figure 3B). We expected that a disturbance of the salt-bridge formation in RIG-I C268F would lead
to a loss of autoimmune signaling. Indeed, mutation of K270 in RecA-like domain A1 renders RIG-I
C268F inactive, probably as the result of a mixture of (i) prevention of the activation of RIG-I C268F
in the absence of ATP by disrupting the salt bridge, and/or (ii) the failure to bind ATP altogether
through impaired ATP phosphate coordination and thus an impaired 2CARD release. In contrast to
our ATP-binding triple mutant R244A, Q247A, C268F, which still allows formation of the salt bridge
in the absence of ATP, mutation of motif I K270 in RIG-I C268F thus renders the protein inactive.
Mutation of E702 in the RecA-like domain 2A of RIG-I C268F, by contrast, does not disrupt constitu-
tive signaling of the protein, although this activity is at a reduced level compared to that of RIG-I
C268F. An explanation for this might be E702’s
localization within the SF2 helicase motif
V, which couples RNA-binding-induced ATP
hydrolysis with movement on dsRNA. Similar to
our previously described V699A mutant in the
same motif (La¨ssig et al., 2015), E702A alone
already induces an autoimmune phenotype simi-
lar to that induced by RIG-I C268F, E702A. The
most plausible explanation for these data is that
RIG-I C268F stabilizes an ATP-like state in the
absence of ATP, but still allows formation of a
proper ATP-bound state. Although E702A could
reduce the former (by disrupting the salt bridge),
it might stabilize the latter by sterically allowing
ATP binding or by increasing the interaction with
RNA.
In summary, our data suggest that the RIG-I
C268F SMS mutation stabilizes the signal-on
state of RIG-I in the presence of RNA but
absence of ATP through a salt bridge between
K270 from domain 1A and E702 from 2A. Unlike
wild type RIG-I, which requires both RNA and
ATP bound in order to be activated for down-
stream signaling, RIG-I C268F can signal indepen-
dently of ATP (Figure 2C) in the presence of
Table 1. Affinities of different RIG-I mutants to MANT-ATP or MANT-ATPgS in the presence or
absence of a 14mer dsRNA. n.d., not determined, n.f., no fit possible as no saturation was reached.
Protein MANT-ATP MANT-ATPgS
RIG-I 72 ± 13 mM 58 ± 7 mM
RIG-I + RNA n.d. 11 ± 1 mM
RIG-I E373Q 72 ± 13 mM n.d
RIG-I E373Q + RNA 28 ± 5 mM n.d
RIG-I K270I 298 ± 81 mM n.d
RIG-I K270I + RNA n.f. n.d
RIG-I C268F 166 ± 34 mM 116 ± 13 mM
RIG-I C268F + RNA n.f. 147 ± 55 mM
DOI: https://doi.org/10.7554/eLife.38958.007
Video 1. Crystal structure of RIG-I D2CARD C268F and
close-up of the active site. The Singleton-Merten
syndrome (SMS) mutation F268, as well as K270 and
E702, are represented by a stick model. Theoretic
locations of ADPBeF3 and Mg
2+ are indicated in faint
sticks and spheres, respectively, according to a
superposition with RIG-I D2CARD in complex with RNA
and nucleotide analogue (PDB 5E3H). K270 is located
at the Mg2+-binding site, whereas E702 occupies the
BeF3 (ATP g-phosphate) position.
DOI: https://doi.org/10.7554/eLife.38958.010
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Figure 3. The RIG-I Singleton-Merten syndrome variant C268F induces amino acid side chain rearrangements within the active site that interfere with
nucleotide binding. (A) ATP-binding pockets of the RIG-I Singleton-Merten syndrome (SMS) variant C268F (left and middle panels) and the RIG-I wild
type (right panel) bound to a 14mer dsRNA. The RIG-I SF2 sub-domains are colored in light gray or light blue (1A and 2A) and dark blue (2B). The RD is
depicted in cyan and 2CARD is indicated in yellow. (B) Fold change of interferon (IFN)-b promoter-driven luciferase activity in uninfected HEK293T RIG-I
KO cells or in cells stimulated with a 19mer 5’-triphosphate (ppp)-dsRNA upon overexpression of different RIG-I mutants. Cells were co-transfected with
RIG-I expression vectors and p-125luc/pGL4.74 reporter plasmids, and stimulated with ppp-dsRNA 6 hr post transfection. Firefly luciferase activities
were determined in respect to Renilla luciferase activities 16 hr after RNA stimulation. All ratios were normalized to an empty vector control. n = 4–12,
error bars represent mean values + SEM.
DOI: https://doi.org/10.7554/eLife.38958.008
The following figure supplement is available for figure 3:
Figure supplement 1. Structural comparison of the RIG-I Singleton-Merten syndrome variant C268F with wild type RIG-I.
DOI: https://doi.org/10.7554/eLife.38958.009
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RNA (Figure 1A). However, our data also show that ATP further increases the binding of RIG-I
C268F to internal dsRNA stems (Figure 1B) and that the engineering of ATP-binding mutations
R244A, Q247A into RIG-I C268F at least partly reduces its signaling activity in response to endoge-
nous or ppp-dsRNA RNA (Figure 2C). Even though we were not able to co-crystalize RIG-I C268F in
the presence of a nucleotide, it is very possible that binding of ATP at high molecular
concentrations, such as those present in a cellular context, further contributes to the pathogenic sig-
naling activity of the protein. In principle, ATP binding would be sterically allowed if the salt-bridge-
forming residue E702 occupies a site as in wtRIG-I. It is not yet clear what happens at the Mg2+-bind-
ing site, as sterically F268 would not allow a canonical positioning of motif I K270 and might thus
prevent binding of Mg2+. Perhaps K270 remains at the displaced site even in the presence of ATP
and simply ‘mimics’ Mg2+. Such a scenario could still lead to reduced binding of ATP but would pre-
vent ATP hydrolysis, as observed, because of a substantially altered charge distribution. This mecha-
nism unifies the molecular basis for the development of SMS by both RIG-I variants (Figure 4).
Unlike wtRIG-I, which consumes ATP and uses ATP turnover to decrease its affinity to self-RNA
(Figure 4A), both motif I and II SMS mutations either mimic or freeze RIG-I in an ATP-bound state
(Figure 4B). As a consequence, the inability to hydrolyze ATP and thus to dissociate actively from
ATP turnover,
translocation
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RD
2CARD
SF2
RIG-I 
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B
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RIG-I E373A
A
T
P
no ATP hydrolysis
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RIG-I  C268F
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?
Figure 4. Model for the impact of Singleton-Merten syndrome mutations on self-RNA-induced RIG-I signaling. (A) In healthy cells, wild type RIG-I
occurs in a signal-off state in which 2CARD is shielded by binding to the insertion domain of SF2. Binding of RIG-I to self-RNAs is efficiently prevented
through ATP-turnover-induced dissociation (for a detailed model on self- vs non-self RNA discrimination see also La¨ssig et al. (2015). (B) RIG-I
Singleton-Merten syndrome (SMS) mutations either slow down ATP hydrolysis and stabilize the ATP-state (E373A, left side) or mimic the ATP-bound
state (C268F, right side), and thus allow formation of the RIG-I signal-on state. In both cases, loss of ATP hydrolysis enhances the interaction with self-
RNA and therefore results in pathogenic signaling. SMS mutations are indicated with a yellow or orange star.
DOI: https://doi.org/10.7554/eLife.38958.011
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RNA (Figure 1B, Figure 2A) traps the protein in an activated state and thus explains autoimmune
signaling in response to self-RNA.
In conclusion, we provide for the first time a detailed biochemical and structural analysis of an
RLR autoimmune disease variant. Slight intramolecular rearrangements within the RIG-I C268F ATP-
binding pocket appear to compensate for ATP binding and render the protein active in the presence
of dsRNA only. At the same time, loss of proof-reading activity leads to increased activation by
endogenous RNA. This unusual gain-of-function mutation reveals, for the first time to our knowl-
edge, that a P-loop mutation can mimic the effects of ATP binding.
Materials and methods
Key resources table
Reagent type (species)
or source Designation Source or reference Identifiers Additional information
Cell line (human) HEK293T RIG-I KO Zhu et al. (2014) Growth in Dulbecco’s Modified Eagle
Medium (DMEM) supplemented with
10% fetal bovine serum (FBS) as
monolayer
Strain, strain
background
(Escherichia coli)
BL21 (DE3) Rosetta Novagene
Strain, strain
background
(Escherichia coli)
DH10multiBac GenevaBiotech
Strain, strain
background
(Spodoptera frugipeda)
Sf21 insect cells Thermo Fisher
Scientific
11497013 Growth in SF-900 III
serum-free medium
Strain, strain
background
(Trichoplusia ni)
High Five insect cells Thermo Fisher
Scientific
B85502 Growth in Express Five serum-free
medium supplemented with
10 mM L-glutamine
Recombinant
DNA reagent
pcDNA5/FRT/TO Thermo Fisher
Scientific
V652020
Recombinant
DNA reagent
pcDNA5/FRT/TO-FLAG/
HA-RIG-I and various
mutants of the same
construct
La¨ssig et al. (2015)
and this paper
Progenitors: PCR, DDX58
(cDNA) and pcDNA5/FRT/TO
Recombinant
DNA reagent
p-125luc Yoneyama et al. (1996) Firefly luciferase controlled
by an interferon-b promoter
Recombinant
DNA reagent
pGL4.74 Promega E6921 Constitutive expression of a
Renilla luciferase
Recombinant
DNA reagent
pFBDM Berger et al. (2004)
Recombinant
DNA reagent
pFBDM-His-RIG-I
and various mutants of
the same construct
La¨ssig et al. (2015)
and this paper
Progenitors: PCR, DDX58 (cDNA)
and pFBDM
Recombinant
DNA reagent
pETM11-SUMO3GFP EMBL Heidelberg,
H. Besir
https://www.embl.de/pepcore/
pepcore_services/cloning/sumo/
Recombinant
DNA reagent
pETM11-SUMO3-RIG-I-
D2CARD-C268F
This paper Progenitors: PCR, DDX58
(cDNA) and pETM11-SUMO3GFP
Sequence-based
reagent
19mer 5’ triphosphate
dsRNA
InvivoGen tlrl-3prna 1 mg/mL, 5’-pppGCAUGC
GACCUCUGUUUGA-3
Sequence-based
reagent
14mer dsRNA Dharmacon 5’-CGACGCUAGCGUCG-3’
Sequence-based
reagent
Cy3-hpRNA Biomers 5’-Cy3-CCACCCGCCCCCCUAGU
GAGGGGGGCGGGCC-3’
Chemical
compound, drug
Lipofectamine 2000 Thermo Fisher
Scientific
11668019 Used at 2.5x excess compared
to RNA/DNA mass
Continued on next page
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Continued
Reagent type (species)
or source Designation Source or reference Identifiers Additional information
Chemical
compound, drug
MANT-ATP Jena Bioscience NU-202
Chemical
compound, drug
MANT-ATPgS Jena Bioscience NU-232
Chemical
compound, drug
[g-32P]ATP Hartmann Analytic SRP-301 10 nM spiked with
3 mM unlabeled ATP
Commercial
assay or kit
Dual-Luciferase
Reporter Assay
System
Promega E1910
Software,
algorithm
XDS, XSCALE Kabsch (2010) http://xds.mpimf-heidelberg.
mpg.de/
Software,
algorithm
PHASER McCoy et al. (2007);
Winn et al. (2011)
http://www.ccp4.ac.uk/
Software,
algorithm
Coot Emsley et al. (2010) https://www2.mrc-lmb.cam
.ac.uk/personal/pemsley/coot/
Software,
algorithm
PHENIX Afonine et al. (2012) https://www.phenix-online.org/
Software,
algorithm
Pymol Schro¨dinger https://pymol.org/2/
Software,
algorithm
R R Development
Core Team (2013)
https://www.r-project.org/
Vectors and cell lines
Sequences encoding full-length (1-925) or N-terminal truncated (230–925 or 232–925) human RIG-I
were cloned into either pcDNA5/FRT/TO (purchased from Thermo Fisher Scientific, Waltham, MA;
for expression in human cells), pFBDM (for expression in insect cells) (Berger et al., 2004) or
pETM11-SUMO3 (EMBL, Heidelberg, Germany; for expression in E. coli). All proteins
that were overexpressed in human cells contained an N-terminal FLAG/HA-tag, whereas proteins
purified from insect cells contained an N-terminal His-tag.
Mutants were generated by site-directed mutagenesis using the QuikChange protocol and PfuUl-
tra polymerase (Agilent, Santa Clara, CA).
HEK293T RIG-I KO cells (Zhu et al., 2014) were maintained in high glucose Dulbecco’s Modified
Eagle Medium (DMEM) supplemented with GlutaMAX, pyruvate and 10% fetal bovine serum (FBS)
(all purchased from Thermo Fisher Scientific, Waltham, MA) at 37˚C/ 5% CO2 and were regularly
tested by PCR for potential mycoplasma contaminations. Spodoptera frugipeda Sf21 and Trichoplu-
sia ni High Five insect cells were maintained at 27˚C/ 150 rpm in SF-900 III serum-free medium and
High Five serum-free medium supplemented with 10 mM L-glutamine, respectively (both purchased
from Thermo Fisher Scientific, Waltham, MA).
Luciferase reporter-gene assays
Transfection-based reporter gene assays in HEK293T RIG-I KO cells were carried out in 96-well tissue
culture plates seeded with 0.2  105 cells one day prior to transfection. Cells were transfected with
25 ng p-125Luc (inducible-expression of a Firefly luciferase controlled by an interferon-b promoter)
(Yoneyama et al., 1996), 5 ng pGL4.74 (constitutive-expression of Renilla luciferase, Promega, Mad-
ison, WI) and varying concentrations of FLAG/HA-RIG-I plasmids (1–200 ng) in a total amount of 300
ng DNA per well (filled up with empty pcDNA5 FRT/TO) using OptiMEM and Lipofectamine 2000
(both Thermo Fisher Scientific, Waltham, MA) according to the vendor’s protocol. After 6 hr, cells
were either stimulated by transfection of 1 mg/mL 19mer 5’triphosphate-dsRNA (InvivoGen, San
Diego, CA) in OptiMEM using Lipofectamine 2000 or the respective amount of OptiMEM alone was
added. Cells were harvested 16 hr after RNA stimulation in 50 mL passive lysis buffer (Promega,
Madison, WI) and frozen at  20˚C until they were used. Luciferase activities were determined with a
Berthold Luminometer in black 96-well plates using 20 mL cell lysate and the Dual-Luciferase
Reporter Assay System (Promega, Madison, WI).
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For competition assays of FLAG/HA-RIG-I C268F with N-terminally shortened FLAG/HA-RIG-I
D2CARD (230-925), cells were seeded as described above. Cells were transfected with 25 ng
p-125Luc, 5 ng pGL4.74, 75 ng FLAG/HA-RIG-I C268F plasmid and varying concentrations (1–195
ng) of competitor plasmids containing N-terminal truncated RIG-I in a total of 300 ng DNA per well
(filled up with empty pcDNA5 FRT/TO) using OptiMEM and Lipofectamine 2000 as transfection
reagent according to the vendor’s protocol. Cells were harvested 16 hr after transfection in 50 mL
passive lysis buffer and frozen at  20˚C. Luciferase activities were determined as described above.
All cell-based assays were performed at least four times in independent experiments and are rep-
resented as mean values + SEM.
Protein expression and purification
Recombinant full-length human RIG-I or RIG-I single amino acid mutants (1–925, N-terminal His-tag)
were produced in and purified from High Five insect cells as described before (Cui et al., 2008;
La¨ssig et al., 2015; Rawling et al., 2015). Briefly, the open reading frame for human RIG-I was
cloned into the pFBDM vector, transformed into E. coli DH10MultiBac, and extracted Baculovirus
DNA was then transfected into SF21 insect cells. Baculoviruses were propagated twice in SF21 insect
cells and subsequently used for infection of High Five insect cells. Expression was carried out for 3
days at 27˚C. Harvested cells were shock frozen in liquid nitrogen and stored at  20˚C until
they were used. For purification, cells were resuspended in lysis buffer (25 mM HEPES, 500 mM
NaCl, 10 mM imidazole, 10% glycerol, 5 mM b-mercaptoethanol, pH 7) and lyzed by sonication.
Cleared lysate was loaded onto Ni-NTA agarose resin (Qiagan, Hilden, Germany), washed with lysis
buffer containing 300 mM NaCl and eluted in elution buffer (25 mM HEPES, 100 mM NaCl, 200 mM
imidazole, 10% glycerol, 5 mM b-mercaptoethanol, pH 7). Proteins were further purified on a HiTrap
Heparin HP column (GE Healthcare, Little Chalfont, UK) in 25 mM HEPES, 10% glycerol, 5 mM b-
mercaptoethanol, pH 7 using a linear salt gradient ranging from 100 mM to 1 M NaCl. Finally, frac-
tions containing RIG-I were pooled and loaded onto a HiLoad Superdex 200 16/60 size exclusion col-
umn (GE Healthcare, Little Chalfont, UK) using gel filtration buffer (25 mM HEPES, 150 mM NaCl, 5
mM MgCl2, 5% glycerol, 5 mM b-mercaptoethanol, pH 7). Monomeric RIG-I was concentrated to ~6
mg/mL, flash frozen in liquid nitrogen and stored at  80˚C. N-terminally truncated RIG-I D2CARD
C268F (232–925, N-terminal His-tag) expressed in High Five cells was purified as described above.
In addition, N-terminally truncated RIG-I D2CARD C268F (232–925, N-terminal His-Sumo3-tag)
was produced in and purified from E. coli Rosetta (DE3). Cells were induced with 0.2 mM DTT at an
OD600 of 0.6–0.8 and protein was expressed at 18˚C overnight. Harvested cells were shock frozen in
liquid nitrogen and stored at  20˚C. Protein was purified as described above, except that after
metal affinity chromatography, the His-SUMO-tag was cleaved off by adding SenP2 protease (mass
ratio 1:500) to pooled eluate fractions during a dialysis step against elution buffer without imidazole
(25 mM HEPES, 100 mM NaCl, 10% glycerol, 5 mM b-mercaptoethanol, pH 7) that was carried out
overnight at 4˚C. Cleaved protein was separated from the tag during a second metal-affinity chro-
matography by step-wise elution with elution buffers containing 20 mM and 40 mM imidazole, and
subjected to heparin-affinity and gel-filtration chromatography as described above.
For crystalization, N-terminally truncated RIG-I D2CARD C268F (purified either from insect cells or
from E. coli) was concentrated to ~25 mg/mL.
Protein crystalization
Co-crystalization of RIG-I D2CARD C268F (170 mM) with equimolar concentrations of 14mer dsRNA
(5’-CGACGCUAGCGUCG-3’, palindromic RNA, purchased from Dharmacon, Lafayette, CO) was
done either in the presence of 2 mM ADP, 2 mM BeCl2 and 10 mM NaF to reconstitute ADPBeFx
(crystal 1) or with 2 mM ATP (crystal 2) by hanging-drop vapor diffusion at 20˚C. In each case, 2.5 mL
protein/RNA/nucleotide mix was added to 2.5 mL reservoir solution from a total reservoir volume of
400 mL per well. Crystal 1 was raised in wells containing 0.1 M MOPS pH 7.5, 15% (w/v) PEG 3350,
0.125 M NaSCN and 3% (v/v) 2,2,2-trifluoroethanol as reservoir solution. The reservoir of crystal 2
contained 0.1 M MOPS pH 7.5, 17.5% (w/v) PEG 3350, 0.25 M NaSCN and 3% (v/v) 2,2,2-trifluoroe-
thanol. Crystals appeared after 1–2 days and were transferred into the respective reservoir solutions
containing 10% (v/v) 2,3-butanediol as cryoprotectant, flash-frozen and stored in liquid nitrogen.
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Data collection and structure determination
X-ray diffraction data were collected at the SLS X06SA beamline (Swiss Light Source, Villigen, Swit-
zerland). Diffraction datasets from both crystals were indexed and integrated using XDS and scaled
with XSCALE (Kabsch, 2010). Crystal 1 had space group P212121 and diffracted to 3.3 A˚, crystal 2
had space group P6522 and diffracted until 2.9 A˚ (Table 2). Diffraction data from crystal 1 were used
to determine an initial structure of RIG-I D2CARD C268F by molecular replacement using PHASER
(McCoy et al., 2007; Winn et al., 2011) and a search model based on a published structure of RIG-I
D2CARD (PDB entry 5E3H) (Jiang et al., 2011). The initial model was created in two iterative rounds
of manual model building and refinement using Coot and PHENIX (Afonine et al., 2012;
Emsley et al., 2010). This model was used to phase the second, better-diffracting dataset from crys-
tal 2 using PHASER. The final structure was built and refined in several iterative rounds using Coot
and PHENIX. The statistics describing both structures are shown in (Table 2). We did not detect any
density for a bound nucleotide in either structure.
Table 2. Data collection and refinement statistics.
Values in parentheses are for the highest resolution shell.
Crystal 1 Crystal 2
PDB code 6GPG
Data collection
Space group P212121 P6522
Wavelength (A˚) 1.00 1.00
Cell dimensions
a, b, c (A˚) 112.1, 177.1, 314.8 175.6, 175.6, 109.5
a, b, g (˚) 90, 90, 90 90, 90, 120
Resolution range (A˚) 47.2–3.3 (3.42–3.30) 46.4–2.9 (3.00–2.89)
Rmerge (%) 14.3 (112) 7.6 (206)
I/sI 8.45 (1.28) 19.72 (1.15)
CC1/2 99.8 (67.6) 99.9 (99.7)
Completeness (%) 95.3 (79.7) 99.7 (97.4)
Redundancy 3.38 (2.91) 13.09 (13.21)
Refinement
Resolution (A˚) 3.3 2.9
No. reflections 90,121 22,649
Rwork/ Rfree 22.8/28.3 21.4/25.9
No. atoms
Macromolecules 35,730 5,810
Ions 10 2
Ramachandran statistics
Favoured (%) 92.78 92.71
Allowed (%) 6.39 6.98
Outliers (%) 0.83 0.31
R.M.S deviations
Bond lengths (A˚) 0.011 0.009
Angles (˚) 1.48 1.43
B-factors
Macromolecules 109.98 139.89
Ions 105.23 121.74
DOI: https://doi.org/10.7554/eLife.38958.012
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Figures and movies were created with PyMOL (Schro¨dinger, 2015).
ATP hydrolysis assays
ATP hydrolysis activities of different full-length His-RIG-I constructs were determined using [g-32P]
ATP (Hartmann Analytic, Braunschweig, Germany). 100 nM protein was pre-incubated with 100 nM
12mer 5’triphosphate-dsRNA for 10 min at room temperature in hydrolysis buffer (25 mM HEPES,
50 mM KCl, 5 mM MgCl2, 5 mM TCEP, pH 7.5). The reaction was initiated by the addition of 3 mM
unlabeled and 10 nM [g-32P]ATP and incubated for 15 min at 37˚C. Free phosphate was separated
from ATP by thin layer chromatography (TLC) in TLC running buffer (1 M formic acid, 0.5 M LiCl) on
polyethyleneimine cellulose TLC plates (Sigma-Aldrich, St. Louis, MO). [g-32P]Pi and [g-
32P]ATP were
detected using the TyphoonTM FLA 9500 phosphor-imaging system (GE Healthcare, Little Chalfont,
UK).
Fluorescence anisotropy
Affinities of full-length RIG-I or RIG-I C268F (1–925, N-terminal His-tag) to a Cy3-labeled hpRNA (5’-
Cy3-CCACCCGCCCCCCUAGUGAGGGGGGCGGGCC-3’, purchased from Biomers, Ulm, Germany)
were determined using fluorescence anisotropy. All samples were prepared in 96-well black chimney
microplates (Greiner Bio-One, Kremsmu¨nster, Austria). 10 nM RNA was pre-incubated with different
protein concentrations (2.4 nM – 5 mM) for 15 min at room temperature in assay buffer (25 mM
HEPES, 50 mM KCl, 5 mM MgCl2, 1 mM DTT, pH 7). Fluorescence anisotropy was measured after
the addition of 5 mM ATP using a TECAN M1000 microplate reader (Tecan, Ma¨nnedorf, Switzerland)
at lex/em = 530/570 nm and gain = 130 during a time course of 25 min in 1 min intervals. Assays
were performed four times in independent experiments using the same protein purification batch.
For determination of affinities, anisotropy values between 15 and 20 min measuring time were aver-
aged and fit to the following single-site binding model using R (R Development Core Team, 2013):
y¼ Bmax
P½ 
P½  þKD
(1)
where y is the observed anisotropy, [P] is the protein concentration, Bmax is the maximal anisotropy
and KD is the dissociation constant. Fitting was performed globally on all available datasets. Repre-
sentative values in figures are mean values ± SD.
MANT-ATP binding
Binding of MANT-ATP and MANT-ATPgS to different full-length RIG-I mutants (1–925, N-terminal
His-tag) was determined via Fo¨rster resonance energy transfer from RIG-I to MANT-ATP (Jena Bio-
science, Jena, Germany). All samples were prepared in 96-well black chimney microplates. 2.2 mM
protein and equimolar concentrations of a 14mer dsRNA (5’-CGACGCUAGCGUCG-3’, see ’Protein
crystalization’) were pre-incubated with different MANT-ATP concentrations (0.2 mM – 200 mM) for
15 min at room temperature in assay buffer (25 mM HEPES, 50 mM NaCl, 5 mM MgCl2, 1 mM DTT,
pH 7). Fluorescence of MANT-ATP was measured in a TECAN M1000 microplate reader at lex/em =
290/448 nm, gain = 170 using an average of five reads per well. Assays were performed four times
in independent experiments using the same protein purification batch. For determination of affinities
fluorescence values were fitted to Equation (1) using R, where y is the fluorescence, [P] is the protein
concentration, Bmax is the maximal fluorescence and KD is the dissociation constant. Fitting was per-
formed globally on all available datasets. Representative values in figures are mean values ± SD.
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